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Abstract
Background: Since both excess glucocorticoid secretion and central obesity are clinical features of some obese
patients, it is worthwhile to study a possible association of glucocorticoid receptor gene (GRL) variants with obesity.
Previous studies have linked the N363S variant of the GRL gene to increased glucocorticoid effects such as higher body
fat, a lower lean-body mass and a larger insulin response to dexamethasone. However, contradictory findings have been
also reported about the association between this variant and obesity phenotypes. Individual studies may lack statistical
power which may result in disparate results. This limitation can be overcome using meta-analytic techniques.
Methods: We conducted a meta-analysis to assess the association between the N363S polymorphism of the GRL gene
and obesity risk. In addition to published research, we included also our own unpublished data -three novel case-control
studies- in the meta-analysis The new case-control studies were conducted in German and Spanish children, adolescents
and adults (total number of subjects: 1,117). Genotype was assessed by PCR-RFLP (Tsp509I). The final formal meta-
analysis included a total number of 5,909 individuals.
Results: The meta-analysis revealed a higher body mass index (BMI) with an overall estimation of +0.18 kg/m2 (95% CI:
+0.004 to +0.35) for homo-/heterozygous carriers of the 363S allele of the GRL gene in comparison to non-carriers.
Moreover, differences in pooled BMI were statistically significant and positive when considering one-group studies from
the literature in which participants had a BMI below 27 kg/m2 (+ 0.41 kg/m2 [95% CI +0.17 to +0.66]), but the differences
in BMI were negative when only our novel data from younger (aged under 45) and normal weight subjects were pooled
together (-0.50 kg/m2 [95% CI -0.84 to -0.17]). The overall risk for obesity for homo-/heterozygous carriers of the 363S
allele was not statistically significant in the meta-analysis (pooled OR = 1.02; 95% CI: 0.56–1.87).
Conclusion: Although certain genotypic effects could be population-specific, we conclude that there is no compelling
evidence that the N363S polymorphism of the GRL gene is associated with either average BMI or obesity risk.
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Since 1990, important efforts have been made to identify
genes influencing complex traits, often by relying on the
use of a priori selected candidate genes. According to the
updated 2004 version of the Human Obesity Map, 113
candidate genes showed initial association with obesity,
out of which only 18 genes are supported by at least five
positive studies [1-3]. Since both excess glucocorticoid
secretion and central obesity are clinical features of some
obese patients, it is worthwhile to study a possible associ-
ation of glucocorticoid receptor gene (GRL) variants with
obesity [4,5]. The GRL gene is located on chromosome
5q31.3 and is also named nuclear receptor subfamily 3,
group C, member 1 (NR3C1). There are three known pol-
ymorphisms in the GRL gene -BclI, ER22/23EK, N363S-
with the last two involved an aminoacid sequence change
[6-17]. The N363S variant of the GRL gene increases the
trans-activating capacity both in vivo e in vitro, and it has
been shown to be associated with an increased sensitivity
to glucocorticoids in vivo. An association of the variant
N363S with measures of increased glucocorticoid effects
such as more body fat, a larger insulin response to dexam-
ethasone and a less lean-body mass has been reported
[5,7].
The polymorphism N363S (rs6195) in exon 2 of the GRL
(U78506) is present with allele frequencies ranging from
0.7% in a South Asian population [13] to 27% in Austral-
ian subjects [12]. This polymorphism was reported to be
associated with an increased body mass index (BMI), an
increased weight gain or a higher waist to hip ratio in
some populations, i. e. in Dutch, Anglo-Celtic, French and
Australian individuals [6,7,11,15,16], while other studies
performed on Danish, Swedish, and South Asian subjects
were not able to confirm this finding [9,10,12-14,17]. The
disparity of the results may partly be attributed to insuffi-
cient power in some of these studies, false positive or neg-
ative findings, or other reasons such as methodological
issues, or the heterogeneity in age, sex, ethnic origin or
average BMI of participants.
To further explore the role of the N363S polymorphism of
the GRL gene in human obesity, we examined novel case-
control data from two Spanish and one German study and
included the results in a meta-analysis of a large number
of previously published studies.
To overcome the limitations of the previous research
work, we pooled data from different studies including our
own results to rigorously assess any association and ascer-
tain the likelihood and magnitude of the association
between the allelic variants and the phenotype of interest
[18-21]. Because non-significant results can be due to type
2 errors, meta-analyses greatly increase the power [20]
and thus reduce the probability of false negative findings.
On the other hand, some of the apparently significant
results are simply due to type 1 errors resulting from spu-
rious findings. Consequently, data pooling also reduces
the type 1 error rate.
Therefore, we performed a meta-analysis by combining
our data from three novel case-control studies (n = 1,117)
with a number of previously reported studies (n = 4,792),
to gain convincing evidence for (or against) the associa-
tion between the N363S polymorphism of the GRL gene
and obesity risk. A family-based study was also conducted
in 124 German obesity trios (obese child or adolescent
and both of their biological parents).
Methods
Study population
The study population was recruited from Spain (Navarra)
and Germany. Two Spanish studies following a case-con-
trol design were conducted as described in detail else-
where [22,23], see Table 1 for phenotypic details. The first
case-control study comprised 370 children and adoles-
cents (185 obese and 185 control subjects). Obesity was
defined according to a body mass index (BMI) above the
97th percentile for sex and age according to Spanish refer-
ence data [22]. Controls had a BMI below the 90th per-
centile. The participants were mostly Caucasians (98.4%)
originating from an homogeneous population of a lim-
ited geographical area in Northern Spain (Navarra) except
for a small proportion of subjects (1.6%) that were non-
Caucasian (3 subjects from South American, 1 Hindu, 1
Afro-American and 1 Gypsy subject). The second (adult)
case-control study included 159 obese subjects with a BMI
≥ 30 kg/m2 and 154 lean controls with BMIs below 25 kg/
Table 1: Phenotypic characteristics of the two Spanish case-control studies
Navarra children Navarra adults
Obese (n = 185) Controls (n = 185) Obese (n = 159) Controls (n = 154)
% Male 53% 53% 12.6% 26.6%
Age (years) 11.4 (11.0–11.8) 11.7 (11.3–12.1) 42 (41–44) 39 (37–40)
BMI (kg/m2) 27.6 (26.9–28.3) 19.0 (18.6–19.4) 37.6 (36.7–38.5) 22.3 (22.0–22.6)
Percentage body fat 34.3 (34.1–36.4) 18.2 (16.8–19.5) 43.4 (42.3–44.6) 27.5 (26.7–28.3)
Data are presented as mean (95%CI).Page 2 of 11
(page number not for citation purposes)
BMC Medical Genetics 2006, 7:50 http://www.biomedcentral.com/1471-2350/7/50m2 [23]. All participants were Caucasians originating from
a homogeneous population of a limited geographical area
in Northern Spain (Navarra). The German study included
178 extremely obese children and adolescents – BMI
above the 99th percentile for age and sex compared to a
representative German population sample [24] – and 256
lean young adults (BMI ≤ 15th percentile) serving as con-
trols. The mean BMI (SD) was 35.6 (6.1) kg/m2 for the
obese group and 18.2 (1.11) kg/m2) for the control group.
50% of the obese subjects and 49% of the controls were
male.
The German study of case-parents encompassed 124
extremely obese children and adolescents (BMI ≥ 99th
BMI percentile according to German reference data [24]
and both of their parents. It is worth mentioning that
obese children and adolescents included in the case-par-
ent study were independent of the individuals included in
the case-control study. All participants of the German
study groups were Caucasians recruited in West and South
Germany.
The study was approved by the Ethics Committee of each
University, and all subjects, (and, in case of minors, their
parents) provided written informed consent. The reported
investigation was carried out according to the principles
of the Declaration of Helsinki II.
Procedures
Extraction of genomic DNA was performed according to
standard protocols. The N363S polymorphism of the GRL
gene was analyzed by PCR-RFLP (digestion with Tsp509I)
as described previously [11]. For validity of the genotypes,
allele determination was made independently by at least
two experienced individuals. Discrepancies were solved
unambiguously either by reaching consensus or by repeat-
ing the experimental procedure. In addition, we checked
for Mendelian inconsistencies in the trios with the pro-
gram Pedcheck [25].
Statistical analysis
Descriptive values are given as mean and standard error of
the mean. Univariate statistical analysis was performed
using unpaired Student t-test and Chi square test (for fre-
quencies).
The Transmission-Disequilibrium Test (TDT) was used to
assess the differential pattern of excess transmission of alle-
les from heterozygous parents to diseased children [26]. By
sampling family trios including the affected children and
adolescents (probands), the association between N363S
allele and obesity would lead to a transmission type differ-
ent from the expected probability of 0.5. When cases are
unrelated probands, TDT represents a valid test of associa-
tion, even if a population stratification is present [26].
Meta-analysis
To systematically review differences in BMI across the
presence/absence of the N363S polymorphism of the GRL
gene (including homozygous and heterozygous subjects
for the 363S allele together) we used a formal meta-anal-
ysis [27]. Procedures of formal meta-analysis have been
mostly applied to combine the results from previously
reported studies[28]. However, in the current meta-analy-
sis, we also included data from three of our own studies
that have not been published yet.
A Pubmed search revealed 16 studies published before
April 2005 focusing on the analysis of the N363S polymor-
phism of the GRL gene in human (obese or lean) subjects.
Subsequently, these were included in the present analysis.
Since new information was required on the frequencies of
the N363S polymorphism of the GRL gene according to
different BMI categories, we personally contacted all
authors to obtain additional information by personal
communication (12 of the 16 studies). Therefore, we were
able to combine data from 12 studies with a total of 4,792
subjects from the literature and data from our present
investigation on 1,117 subjects. Thus, the total number of
subjects in the meta-analysis was 5,909 subjects.
The meta-analysis provides a logical structure for system-
atically quantifying evidence and for exploring bias and
diversity in research[27]. In our meta-analysis, the pres-
ence/absence of the polymorphism was considered as the
exposure, whereas a change in BMI was considered as the
outcome. The average difference in BMI between individ-
uals with or without the N363S polymorphism (homo-/
heterozygous carriers of the 363S allele vs. non-carriers) of
the GRL gene was used as the outcome.
We estimated a summary difference (ds) as the weighted
effect size [29]:
ds = diwiwi
ds is the pooled estimate across studies for the difference
in the BMI (kg/m2) in homo-/heterozygous carriers and
non-carriers of 363Ser allele, wi is the weight assigned to
each study (wi is the inverse of the variance for the differ-
ence in BMI found in each study) and di is the BMI differ-
ence between those with or without the N363S
polymorphism in each individual study. We also calcu-
lated a 95% confidence interval (CI) for the pooled differ-
ence in BMI:
95% CI = ds ± (1.96 × SE)
where SE is the standard error of the pooled estimate [27].Page 3 of 11
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statistic, which follows a Chi-square distribution with
degrees of freedom of k-1, k being the number of studies
included in the analysis. A two-tailed p value < 0.05 for
this statistic parameter indicates the presence of heteroge-
neity, which somewhat compromises the validity of the
pooled estimates [30]. For the pooled odds ratio we used
the DerSimonian and Laird's random effect model [31].
Because significant heterogeneity was clearly evident in
the pooled difference estimates for all studies combined,
we evaluated potential sources of heterogeneity by subset
analysis [27]. We analysed sub-groups using the following
criteria: firstly, unpublished studies which included six
datasets from the present investigation considering obese
and control subjects and children and adolescents vs.
adult subjects; secondly, published studies with one pop-
ulation group (nine studies); thirdly, published studies
with two groups – an obese and a lean subject group
(three studies, six datasets). We also repeated the meta-
analysis in subgroups built according to the prevalence of
the mutation -homo-/heterozygous carriers- (<5%; 5–
10%: >10%), according to ethnicity, and according to the
gender of participants.
Results
Studies on Spanish and German populations
In this work, firstly we examined the N363S polymor-
phism of the GRL gene in two Spanish case-control stud-
ies. The main phenotypic characteristics of the Spanish
adults and children study groups are given in Table 1. The
German population was composed of 178 extremely
obese children and adolescents (mean age 14, 50% boys)
and 256 lean young adults (mean age 25, 50% male) as
indicated in the Methods section.
The percentages of homo-/heterozygous carriers of the
363S allele of the GRL gene for each study group are
shown in Table 2. Values ranged from 1.26% in the Span-
ish adult obese subjects to 8.59% in the German control
Table 2: Mean and difference (95% CI) in body mass index (kg/m2) between individuals homozygous and heterozygous carriers of the 
363S allele of the GRL gene and homozygotes for the N363 allele in studies with two population group
Normal weight subjects Obese subjects
Study N363/363S 
363S/363S
N363/N363 Mean 
difference
95% CI % 
carriers
N363/363S 
363S/363S
N363/N363 Mean 
difference
95% CI % 
carriers
n Mean 
BMI
n Mean 
BMI
n Mean 
BMI
n Mean 
BMI
Published 
data
Lin et al. 
1999
27 26.5 171 25.7 0.8 -0.9 2.5 13.64 39 43.6 107 42.9 0.7 -2.5 3.8 26.71
Lin et al. 
2003
33 26.6 230 25.6 1.0 -0.5 2.5 12.55 39 43.5 111 43.1 0.4 -2.7 3.5 26.00
Echwald et 
al. 2001
79 26.4 775 26.1 0.2 -0.6 1.1 9.25 66 35.9 675 35.7 0.2 -1.2 1.7 8.91
Total (n) 139 1176 144 893
Novel data
Spain 
(Navarra)
Adults 7 22.4 147 22.3 0.1 -1.3 1.4 4.54 2 37.1 157 37.6 -0.5 -8.5 7.5 1.26
Children 8 18.6 177 18.9 -0.3 -2.2 1.6 4.32 4 24.3 181 27.6 -3.3 -7.9 1.3 2.16
Germany
Children and 
adolescents
22 17.6 234 18.3 -0.7 -1.2 -0.2 8.59 8 41.3 170 35.4 5.9 1.7 10.2 4.49
Total (n) 37 558 14 508
In the study by Echwald et al (2001) only men were recruited from Copenhagen, Denmark, mean age = 45. The study by Lin et al (1999) included 
men (53%) and women (47%), mean age = 50, from Sydney (Australia), the study by Lin et al (2003) included men (80%) and women (20%), mean 
age = 45, from Sydney (Australia). The Navarra adults study enrolled men (20%) and women (80%), mean age = 40, from Navarra (North of Spain). 
The Navarra children study encompassed boys (53%) and girls (53%), mean age = 11 from Navarra (North of Spain). The German children study 
consisted of boys (50%) and girls (50%), mean age = 14 from West and South of Germany.Page 4 of 11
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participants and in controls versus obese subjects. All
Spanish carriers were heterozygous for the polymorphism
N363S of the GRL gene. Only one homozygous carrier for
the 363S allele was found among the German extremely
obese children and adolescents. All study groups fulfilled
Hardy-Weinberg equilibrium.
Apart from these three study groups, a family-based asso-
ciation study was also conducted separately in 124 Ger-
man trios. 15 parents were heterozygous for the N363S
polymorphism of the GRL gene, of which 8 transmitted
the allele 363S (p-value = 0.99). Hence, we detected no
transmission disequilibrium for the N363S polymor-
phism of the GRL gene in the population studied.
Published studies included in the meta-analysis
The number and mean BMI for homo-/heterozygous car-
riers the 363S allele of each study are described in Table 2
(studies with one obese and one normal weight subject
group) and Table 3 (only one group). We combined data
from 12 studies from the literature having either one or
two groups of subjects (cases and controls) with a total of
4,792 subjects. As seen in Table 4, we performed several
types of analysis. We pooled published studies with only
one group (9 studies), unpublished studies including 6
datasets from the three studies of the present investiga-
tion, considering obese and control subjects separately;
and published studies with two groups of subjects (three
studies).
When analyzing data from one-population studies (Table
4), a subgroup of four studies was generated considering
only reports including participants with BMI values below
27 kg/m2. For this group, the pooled difference in BMI
values was statistically significant (+0.41 kg/m2; [95% CI:
+0.17 to +0.66]) for 363S homo-/heterozygous carriers of
the 363S allele compared to non-carriers.
We also examined the pooled difference in BMI between
homo-/heterozygous carriers and non-carriers of the 363S
allele of the GRL gene in published articles with two pop-
ulation groups: a group of controls (normal weight sub-
jects) and a group of cases (obese subjects). The pooled
difference in BMI between homo-/heterozygous carriers
and non-carriers of the 363 allele was not statistically sig-
nificant when studies with normal weight subjects (+0.56
kg/m2; [95% CI: -0.072 to +1.19]) and obese subjects
(+0.32 kg/m2 [95% CI: -0.82 to +1.46]) were considered
separately. However, the pooled difference in BMI was
negative and statistically significant in homo-/hetero-
zygous carriers of the S363 allele when only novel data for
normal weight subjects were examined (-0.50 kg/m2;
[95% CI: -0.84 to -0.17]). Opposite tendencies for differ-
ences in BMI were also found when performing the meta-
analysis after stratifying by gender, prevalence of the pol-
Table 3: Mean and difference (95% CI) in body mass index (kg/m2) between individuals homozygous and heterozygous carriers of the 
363S allele of the GRL gene and homozygotes for the N363 allele in studies with one population group
Study 363S/N363 363S/
363S
N363/N363 Mean difference % 
carriers
City, origin Age, 
gender
Ref.
n Mean 
BMI
n Mean 
BMI
95% CI
Huizenga 98 12 28.1 198 26.6 1.5 1.3 1.7 5.7 Rotterdam, 
Netherlands
66–68, 
both
6
Halsall 00 38 26.3 453 25.8 0.5 0.4 0.6 7.7 Isle of Ely, 
UK
54, NA 7
Rosmond 01 25 26.0 243 26.2 -0.2 -1.8 1.4 9.3 Gotenburg, 
Sweden
NA, men 8
Dobson 01 23 26.1 352 26.6 -0.5 -2.6 1.7 6.1 Newcastle, 
UK
54, both 9
Morris 03 46 41.7 122 45.0 -3.3 -6.3 -0.3 27.4 Sydney, 
Australia
NA, NA 11
Rosmond 03 15 27.5 141 27.1 0.4 -1.6 2.4 9.6 Sävedalen, 
Sweden
NA, men 10
Roussel 03 20 29.6 349 28.0 1.6 -0.5 3.7 5.4 Paris, France 62, both 12
Wüst 04 16 21.1 92 22.0 -0.8 -2.4 0.7 14.8 Trier, 
Germany
18, men 14
Syed 04 2 28.2 293 27.1 1.1 -5.3 7.4 0.7 South Asian, 
UK
51, both 13
Total (n) 197 2243
NA: not availablePage 5 of 11
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tions, separately (Table 4).
We then estimated pooled odds ratios (ORs) and their
95% confidence intervals (CIs) to further explore the asso-
ciation between the N363S polymorphism of the GRL
gene and the likelihood of being obese (Figures 1, 2, 3).
The relative risk of obesity linked to the N363S polymor-
phism was not significant (pooled OR = 1.71; [95% CI:
0.88–3.33]), when data from previously published
reports were used. If only the new data obtained from the
present investigation were included, the OR for obesity of
homo-/heterozygous carriers of the 363S allele was statis-
tically significant, but in the opposite direction (pooled
OR = 0.45; [95% CI: 0.24–0.85]). When these new data
were pooled with previous findings in the meta-analysis,
the overall risk of obesity linked to the polymorphism
N363S was not statistically significant, revealing a pooled
OR of 1.02 [95% CI: 0.56–1.87].
Discussion
The present study was aimed to assess the effect of the
N363S polymorphism of the GRL gene on the incidence
of obesity. Although procedures of meta-analyses have
mostly been applied to comprehensively examine the
results from previously reported studies, we here also
include novel data from three studies derived from Span-
ish and German populations of our group that have not
been published so far. Moreover, the meta-analysis was
performed only after relevant data that were not available
in the original publications were obtained contacting
directly with the authors. The new data set was generated
using two different strategies: the first was to match con-
trols to cases by gender and age, whereas the second one
was performed as a case-parent study that can be consid-
ered as a special type of case-control study in which cases
(unrelated probands) and pseudocontrols (parental non-
transmitted alleles) are matched by ethnic origin. The
magnitude of the association can be assessed by odds
ratios (OR) in the case-control study, while the deviations
of the transmission probabilities from the expected value
under the null hypothesis of no-association (50%) are
related to the genotype relative risk [32]. The close prox-
imity of point estimates for ORs (Figure 3) with values
below 1.0 and the transmission probabilities found in the
case-parent study do not suggest a positive association
between the N363S polymorphism of the GRL gene and
childhood obesity in the German population.
Table 4: Pooled differences (95% CI) in body mass index (kg/m2) between individuals homozygous and heterozygous carriers of the 
363S allele of the GRL gene and homozygotes for the N363 allele. Fixed effects model
Studies Difference in BMI (kg/m2) 
Pooled estimates
95% CI Q statistic k p#
Overall studies +0.18 +0.004 to +0.35* 84.47 21 <0.0001
BMI < 27 kg/m2 +0.14 -0.052 to +0.32 29.15 10 0.0006
BMI > 27 kg/m2 +0.37 -0.047 to +0.79 54.31 11 <0.0001
Adults (>25 years) +0.51 +0.31 to +0.72* 27.47 16 0.0252
Children and adolescents (<25 years) -0.67 -0.99 to -0.35* 19.94 5 0.0005
- Ethnicity
European Countries +0.16 -0.01 to +0.34 74.84 15 <0.0001
Australia +0.45 -0.34 to +1.24 9.03 5 0.06
- Gender
Men -0.37 -1.25 to +0.51 1.20 3 0.5487
Men and women +0.20 +0.02 to +0.37 81.76 18 <0.0001
- Mutation prevalence
(<5%) -0.54 -0.96 to -0.12 20.69 6 0.0009
(5–10%) +0.34 +0.15 to +0.54 37.74 9 <0.0001
(>10%) +0.10 -0.57 to +0.77 11.84 6 0.037
One population
BMI < 27 kg/m2 +0.41 +0.17 to +0.66* 5.88 4 0.1177
BMI ≥ 27 kg/m2 +1.19 +0.64 to +1.74* 13.34 5 0.0097
Normal weight subjects
already published data +0.56 -0.07 to +1.19 1.04 3 0.5941
novel data -0.50 -0.84 to -0.17* 1.72 3 0.4227
Obese subjects
already published data +0.32 -0.82 to +1.46 0.07 3 0.9633
novel data -1.26 -2.10 to -0.49* 15.77 3 <0.001
k: number of studies;
# test for heterogeneity;
* p < 0.05 for the pooled difference in BMI.Page 6 of 11
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polymorphism of the GRL gene and found it to be slightly
more frequent in the German than in the Spanish study
groups. Across populations, the genotype frequency of the
polymorphism of the GRL gene varies widely. In Europe,
it ranges from 4% to 6% for homo-/heterozygous carriers
of the 363S allele in German, Spanish, French or British
subjects and between 9% and 15% in Swedish and Danish
individuals [6,10,11,14,17] Australian populations have
higher frequencies of homo-/heterozygous carriers of the
363S-allele, ranging from 12–13% in normal weight indi-
viduals to 26–27% in obese subjects (Tables 2 and 3;
[12,15,16]). There are also important differences in the
genotype frequency of the polymorphism in obese and
non-obese subjects in several other populations. Surpris-
ingly, for the Spanish and German normal weight groups,
the number of homo-/heterozygous carriers of the 363S
allele of the GRL gene was higher compared to that found
in obese subjects of the same population groups (Table
3).
To confirm the strength of our findings and because
inconsistent data have been reported on the relationship
between the N363S polymorphism of the GRL gene and
obesity phenotypes [33, 34], after adding our own new
data to previously published results, data from 5,909
unrelated subjects from a diverse ethnic backgrounds were
pooled together for the analysis of BMI differences
between homo-/heterozygous carriers and non-carriers of
the 363S allele of the GRL gene. The overall pooled esti-
mated genotype frequency for homo-/heterozygous carri-
ers of the 363S allele was 4.47% (95% CI: 4.24–5.30) with
a substantial heterogeneity (p < 0.001). Interestingly, for
BMI differences, the overall estimation was +0.18 kg/m2
(95% CI: +0.004 to +0.35) higher in homo-/heterozygous
carriers of 363S allele of the GRL gene than in non-carri-
Odds Ratios with the 95% CI for the association between presence of the N363S polymorphism of the GRL gene and the like-lihood of being obes in the ove all studiesFigure 1
Odds Ratios with the 95% CI for the association between presence of the N363S polymorphism of the GRL 
gene and the likelihood of being obese in the overall studies. In the study by Echwald et al (2001) only men were 
recruited from Copenhagen, Denmark, mean age = 45. The study by Lin et al (1999) included men (53%) and women (47%), 
mean age = 50, from Sydney (Australia), the study by Lin et al (2003) included men (80%) and women (20%), mean age = 45, 
from Sydney (Australia). The Navarra adults study enrolled men (20%) and women (80%), mean age = 40, from Navarra 
(North of Spain). The Navarra children study encompassed boys (53%) and girls (53%), mean age = 11 from Navarra (North of 
Spain). The German children study consisted of boys (50%) and girls (50%), mean age = 14 from West and South Germany. 
Test for heterogeneity Q = 24.2; 5 df; p < 0.01.
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Navarra adults
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Echwald 0.96 (0.67, 1.37)
0.50 (0.19, 1.20)
Navarra children 0.49 (0.11, 1.87)
Lin 2003 2.45 (1.41, 4.25)
Lin 1999 2.31 (1.29, 4.16)
combined [random] 1.02 (0.56, 1.87)
odds ratio (95% confidence interval)
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worthwhile to mention that the pooled analysis (i.e. the
"one population studies") revealed a large range for BMI:
from non-obese (mean BMI = 21.1 kg/m2, ref. 14) to
severely-obese individuals (mean BMI = 41.7 kg/m2, ref
11) and also with regard to age: from 18 years [14] to 66–
68 years [7]. Moreover, three studies were only conducted
with men [9,10,14], while four studies included male and
female subjects [6,7,11,13]. Disparities in BMI across
studies as well as age and sex variability may at least partly
account for the observed heterogeneity (Table 2).
Interestingly, when a subgroup of data was generated con-
sidering only reports whose participants showed a BMI
below 27 kg/m2, the pooled difference in BMI values for
homo-/heterozygous carriers of the 363S allele vs. non-
carriers was statistically significant and homogeneous
(+0.41 kg/m2; 95% CI: +0.17 to +0.66) with a p-value for
heterogeneity of 0.12. Funnel plots of effect estimates (dif-
ferences in BMI) against sample size showed symmetrical
distribution suggesting that there was no apparent publi-
cation bias in the available studies.
With regard to the meta-analysis, a drawback of the OR
analysis is the use of different criteria to define obese and
non-obese individuals in the various studies. Some exam-
inations (e.g. Echwald et al. 2001, and Navarra studies)
were based on rather low BMI thresholds for obesity,
whereas others included morbidly-obese patients with
BMI values well above 35 kg/m2[16]. Moreover, there are
important differences in age and sex among the groups
analysed. Because the respective information was not pro-
vided in all studies, age and sex effects could not be ade-
quately addressed in the current meta-analysis.
Two groups of children and adolescents (boys and girls)
were included in the German and Spanish studies as well
as one large group of young men with a mean age of about
27 years [17]. The other three studies were conducted in
adults. In two studies [15,16], the criteria for age and per-
Odds Ratios with the 95% CI for the association between presence of the N363S polymorphism of the GRL gene and the like-lihood of being obes in the publis d tud esFigure 2
Odds Ratios with the 95% CI for the association between presence of the N363S polymorphism of the GRL 
gene and the likelihood of being obese in the published studies. In the study by Echwald et al (2001) only men, mean 
age = 45, were recruited from Copenhagen, Denmark. The study by Lin et al (1999) included men (53%) and women (47%), 
mean age = 50, from Sydney (Australia), the study by Lin et al (2003) included men (80%) and women (20%), mean age = 45, 
from Sydney (Australia). Test for heterogeneity Q = 12.3; 2 df; p < 0.01.
0.5
Echwald  0.96 (0.67, 1.37)
Lin 2003  2.45 (1.41, 4.25)
Lin 1999 2.31 (1.29, 4.16)
combined [random] 1.71 (0.88, 3.33)
odds ratio (95% confidence interval)
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BMC Medical Genetics 2006, 7:50 http://www.biomedcentral.com/1471-2350/7/50centage of males were quite similar -an age range of 48–
52 years and a percentage of 49–57% of males- while in
the third, the mean age of subjects was different (39–42
years old) as was the percentage of males (12–26%, Table
1).
Overall, our analyses did not indicate an increased risk for
the development of obesity for homo-/heterozygous car-
riers of the S363 allele of the GLR as shown by a pooled
OR of 1.02 (95% CI: 0.56–1.87). Interestingly, an inverse
association (OR = 0.45) was obtained after pooling the
German and Spanish studies for homo-/heterozygous car-
riers of the 363S allele compared to non-carriers, suggest-
ing population differences for this parameter. Beyond the
already mentioned limitations of our meta-analysis, our
study provides a sound base for the further investigation
on the role of the polymorphism N363S of the GRL gene
in large population samples of diverse ethnic origins [34].
It also yields a much better opportunity for the detection
of significant effects in sub-group analyses of homogene-
ous data. Thus, the meta-analysis represents a useful strat-
egy to assess the potential contribution of variants with
rather low allele frequencies (i.e. the N363S polymor-
phism of the GRL from 4 to 9%), which may exert only
moderate effects on polygenic disorders.
Conclusion
Although certain genotypic effects could be population-
specific, we conclude that there was no compelling evi-
dence that the N363S polymorphism of the GRL gene is
associated with the average BMI or with an increased prev-
alence of obesity, in the large number of human studies
included in our analyses.
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Odds Ratios with the 95% CI for the association between presence of the N363S polymorphism of the GRL gene and the like-lihood of being obes in the unpublished stud esFigure 3
Odds Ratios with the 95% CI for the association between presence of the N363S polymorphism of the GRL 
gene and the likelihood of being obese in the unpublished studies. The Navarra adults study enrolled men (20%) and 
women (80%), mean age = 40, from Navarra (North of Spain). The Navarra children study encompassed boys (53%) and girls 
(53%), mean age = 11 from Navarra (North of Spain). The German children study consisted of boys (50%) and girls (50%), 
mean age = 14 from West and South Germany. Test for heterogeneity Q = 0.49; 2 df; p = 0.78.
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